Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Consolidated Net Income rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 707.61%. This contributed to the annual value of -$39.3 million for FY2024, which is 632.44% up from last year.
  • Latest data reveals that Jaguar Health reported Consolidated Net Income of -$9.6 million as of Q3 2025, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Jaguar Health's 5-year Consolidated Net Income high stood at -$7.9 million for Q3 2023, and its period low was -$18.2 million during Q1 2022.
  • For the 5-year period, Jaguar Health's Consolidated Net Income averaged around -$11.2 million, with its median value being -$10.6 million (2025).
  • Per our database at Business Quant, Jaguar Health's Consolidated Net Income plummeted by 6327.97% in 2021 and then soared by 4250.59% in 2022.
  • Over the past 5 years, Jaguar Health's Consolidated Net Income (Quarter) stood at -$14.3 million in 2021, then soared by 42.51% to -$8.2 million in 2022, then fell by 13.08% to -$9.3 million in 2023, then decreased by 9.94% to -$10.2 million in 2024, then grew by 5.73% to -$9.6 million in 2025.
  • Its Consolidated Net Income stands at -$9.6 million for Q3 2025, versus -$10.6 million for Q2 2025 and -$10.6 million for Q1 2025.